Qyuns Therapeutics Co., Ltd. (2509.HK)
Qyuns Therapeutics Co., Ltd., a clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in China.
16.30+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-23.7%
The outlook
Qyuns Therapeutics Co., Ltd. currently reads as leaning bullish based on strong buy — 1.0 avg of 1 analysts, mixed vs its moving averages, 13% of the way from its 52-week low to high, avg target +102% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 1 analysts
Price trendMixed vs its moving averages
52-week range13% of the way from its 52-week low to high
Price targetAvg target +102% vs current price
Market cap
$3.64B
52-wk high
36.50
52-wk low
13.21
50-day avg
15.52
200-day avg
18.97
Trailing P/E
10.0